Multicenter, real-world experience with lenvatinib for patients with advanced hepatocellular carcinoma in Japan

被引：0
|
作者：
Sho, Takuya [1 ]
Suda, Goki [1 ]
Ogawa, Koji [1 ]
Nakai, Masato [1 ]
Morikawa, Kenichi [1 ]
Sakamoto., Naoya [1 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT510
引用
收藏
页码：S909 / S909
页数：1
相关论文
共 50 条
  • [21] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Kim, Mijin
    Ahn, Jonghwa
    Song, Dong Eun
    Yoon, Jee Hee
    Kang, Ho-Cheol
    Lim, Dong Jun
    Kim, Won Gu
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kim, Bo Hyun
    ENDOCRINE, 2021, 71 (02) : 427 - 433
  • [22] A nationwide multicenter study in patients with unresectable hepatocellular carcinoma treated with lenvatinib in real world practice in Japan.
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Kaneko, Shun
    Kimura, Toru
    Marusawa, Hiroyuki
    Arai, Hirotaka
    Abe, Takehiko
    Kimura, Hiroyuki
    Tsuji, Keiji
    Furuta, Koichiro
    Ogawa, Chikara
    Narita, Ryoichi
    Kojima, Yuji
    Akahane, Takehiro
    Uchida, Yasushi
    Yoshida, Hideo
    Kobashi, Haruhiko
    Kusakabe, Atsunori
    Joko, Kouji
    Izumi, Namiki
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [23] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma:A retrospective,real-world study conducted in China
    Dong-Xu Wang
    Xu Yang
    Jian-Zhen Lin
    Yi Bai
    Jun-Yu Long
    Xiao-Bo Yang
    Samuel Seery
    Hai-Tao Zhao
    World Journal of Gastroenterology, 2020, (30) : 4465 - 4478
  • [24] Population Pharmacokinetic Modeling of Lenvatinib in Chinese Patients With Advanced Hepatocellular Carcinoma Using Real-World Data
    Hu, Yingying
    Chen, Ruijia
    Ye, Zhenjie
    Wei, Fuqun
    Lin, Kecan
    Liu, Jingfeng
    Zeng, Yongyi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (12): : 1507 - 1517
  • [25] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [26] Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Kuo, Yuan-Hung
    Lu, Sheng-Nan
    Chen, Yen-Yang
    Kee, Kwong-Ming
    Yen, Yi-Hao
    Hung, Chao-Hung
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Wang, Jing-Houng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study
    Ross, Paul J.
    Ma, Yuk Ting
    Palmer, Daniel H.
    Lythgoe, Mark Peter
    Merrick, Sophie
    Samson, Adel
    Rao, Ankit Rohit
    Basu, Bristi
    Prasad, Debi
    Dhillon, Tony
    Lau, David
    Darby, Suzanne
    Orr, James
    Margetts, Jane
    Hubner, Richard
    Baijal, Shobhit
    Sharma, Rohini
    Faluyi, Olusola Olusesan
    Lee, Lennard
    Thillai, Kiruthikah
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [28] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    HEPATOLOGY, 2020, 72 : 689A - 689A
  • [29] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Marusawa, Hiroyuki
    Kojima, Yuji
    Hasebe, Chitomi
    Arai, Hirotaka
    Joko, Kouji
    Kondo, Masahiko
    Tsuji, Keiji
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Ogawa, Chikara
    Uchida, Yasushi
    Wada, Shuichi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Shigeno, Masaya
    Kusakabe, Atsunori
    Akahane, Takehiro
    Narita, Ryoichi
    Yoshida, Hideo
    Mitsuda, Akeri
    Ide, Yasushi
    Matsushita, Tomomichi
    Izumi, Namiki
    CANCERS, 2021, 13 (11)
  • [30] Real-world experience of pembrolizumab plus lenvatinib in unresectable hepatocellular carcinoma in Taiwan.
    Wu, Chi-Jung
    Hung, Ya-Wen
    Lee, Pei-Chang
    Lee, ChiehJu
    Chen, Ming Huang
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345